Literature DB >> 33971816

Correction to: Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation.

Yaru Huang1, Xiaotong Sun1, Zhaodong Juan2, Rui Zhang1, Ruoguo Wang3, Shuqi Meng1, Jiajia Zhou1, Yan Li1, Keyou Xu1, Keliang Xie4.   

Abstract

Entities:  

Year:  2021        PMID： 33971816     DOI： 10.1186/s12871-021-01356-z

Source DB:  PubMed          Journal:  BMC Anesthesiol        ISSN： 1471-2253            Impact factor:   2.217


× No keyword cloud information.
  1 in total

1.  Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation.

Authors:  Yaru Huang; Xiaotong Sun; Zhaodong Juan; Rui Zhang; Ruoguo Wang; Shuqi Meng; Jiajia Zhou; Yan Li; Keyou Xu; Keliang Xie
Journal:  BMC Anesthesiol       Date:  2021-04-06       Impact factor: 2.217
  1 in total
  1 in total

1.  Interleukin 38 alleviates aortic valve calcification by inhibition of NLRP3.

Authors:  Erlinda The; Dennis M de Graaf; Yufeng Zhai; Qingzhou Yao; Lihua Ao; David A Fullerton; Charles A Dinarello; Xianzhong Meng
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.